Frequency and characteristics of HTLV in migrants: results from the +Redivi collaborative network in Spain.


Journal

Journal of travel medicine
ISSN: 1708-8305
Titre abrégé: J Travel Med
Pays: England
ID NLM: 9434456

Informations de publication

Date de publication:
04 11 2022
Historique:
received: 09 12 2021
revised: 21 01 2022
accepted: 09 02 2022
pubmed: 16 2 2022
medline: 9 11 2022
entrez: 15 2 2022
Statut: ppublish

Résumé

The objective of this study was to describe the main characteristics of migrants diagnosed with human T-lymphotropic virus (HTLV) infection within the +Redivi Spanish network. Patients with a diagnosis of HTLV type 1 or 2 in +Redivi from October 2009 to December 2020 were included. Diagnosis was based on positive HTLV serology (enzyme-linked immunosorbent assay (ELISA)/chemiluminescent immunoassay (CLIA)) with line immunoassay (LIA)/Western blot with/without polymerase chain reaction (PCR). A total of 107/17 007 cases (0.6%) had a final diagnosis of HTLV infection: 83 (77.67%) HTLV-1 infections, 6 (5.6%) HTLV-2 infections and 18 (16.8%) non-specified. The majority (76, 71%) were female, median age was 42 years and median time from arrival to Spain until consultation was 10 years. The group included 100 (93.5%) immigrants and 7 (6.6%) visiting friends and relatives (VFR)-immigrants. Most patients were from South America (71, 66.4%), followed by Sub-Saharan Africa (15, 14%) and Central America-Caribbean (13, 12.1%). Around 90% of patients were asymptomatic at presentation and diagnosed as part of screening programs. Median duration of follow-up was 5 years (IQR 2-7). Regarding HTLV-associated conditions, 90 patients (84.2%) had none, 7 (6.5%) had tropical spastic paraparesis , 5 (4.7%) had other associated conditions (dermatitis, uveitis, pulmonary disease), 3 (2.8%) had other neurological symptoms and 2 (1.9%) had adult T-cell leukaemia/lymphoma. No patients with HTLV-2 had HTLV-associated conditions. Four patients (3.7%) died. Concomitant diagnoses were found in 41 (38.3%) patients, including strongyloidiasis in 15 (14%) and HIV co-infection in 4 (3.7%). In 70% of patients, screening of potential contacts was not performed/recorded. HTLV infections (the majority due to HTLV-1) were mainly diagnosed in asymptomatic migrants from Latin America (generally long-settled immigrants and the majority female with the consequent implications for screening/prevention). A high rate of association with strongyloidiasis was found. In the majority, screening of potential contacts was not performed, representing a missed opportunity for decreasing the under diagnosis of this infection.

Identifiants

pubmed: 35166822
pii: 6528728
doi: 10.1093/jtm/taac019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of International Society of Travel Medicine. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Francesca F Norman (FF)

National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, IRYCIS, CIBER de Enfermedades Infecciosas, Madrid, Spain.

Fernando Salvador (F)

Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Spain.

Beatriz Gullón (B)

National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, IRYCIS, CIBER de Enfermedades Infecciosas, Madrid, Spain.

Marta Díaz-Menéndez (M)

National Referral Centre for Imported Tropical diseases, Hospital Universitario La Paz-Carlos III, Madrid, Spain.

Ana Pérez-Ayala (A)

12 de Octubre University Hospital, Madrid, Spain.

Azucena Rodriguez-Guardado (A)

Asturias Central University Hospital, Oviedo, Spain.

Magdalena García-Rodriguez (M)

Valencia General University Hospital, Valencia, Spain.

Cesar Henriquez-Camacho (C)

Rey Juan Carlos University Hospital, Madrid, Spain.

Josune Goikoetxea (J)

Cruces University Hospital, Barakaldo, Spain.

Pau Bosch-Nicolau (P)

Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Spain.

Fernando de la Calle (F)

National Referral Centre for Imported Tropical diseases, Hospital Universitario La Paz-Carlos III, Madrid, Spain.

Jose-Manuel Ramos-Rincon (JM)

Alicante General University Hospital, Alicante, Spain.

Maria-Luisa Aznar (ML)

Unitat de Medicina Tropical y Salut Internacional Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Spain.

María Peñaranda (M)

Son Espases University Hospital, Islas Baleares, Spain.

Eva Calabuig (E)

Unidad de Enfermedades Infecciosas, La Fe University and Polytechnic Hospital, Medicine Department, University of Valencia, Valencia, Spain.

Ines Suarez-Garcia (I)

Infanta Sofía University Hospital, Madrid, Spain.

Jose A Pérez-Molina (JA)

National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, IRYCIS, CIBER de Enfermedades Infecciosas, Madrid, Spain.

Rogelio López-Vélez (R)

National Referral Unit for Tropical Diseases, Infectious Diseases Department, Ramón y Cajal University Hospital, IRYCIS, CIBER de Enfermedades Infecciosas, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH